Table 1.
Most used lipids in TSL preparation.
| Composition | Drug | Ref |
|---|---|---|
| DPPC/CH/DSPE-PEG2000)/DSPE-PEG(2000)-Folate | DOX | [31] |
| DPPC/HSPC/CH/DPPE-PEG2000/DOTA-DSPE | DOX + GD | [32] |
| DPPC/DSPC/DPPGOGDPPC/P-lyso-PC/DSPE-PEG2000 | DOX | [33] |
| DPPC/P-lyso-PC/DSPE-PEG2000 | DOX | [34,35] |
| DPPC/HSPC/CH/DSPE-PEG2000 | DOX | [26] |
| DPPC/DSPC/DSPE-PEG200055:40:580:15:5 | DOX | [36] |
| DPPC/DSPCDPPC/DSPC/DPPGOG | CF | [37] |
| DPPC:MSPC:DSPG:DSPE-mPEG200082:8:10:4 | Epirubicin | [38] |
| DPPC:MSPC:DSPE-PEG2000:DSPG83:3:10:4 | Paclitaxel | [39] |
| DPPC:DSPE:PEG2000:EPC:MSPC82:11:4:3:4 | Docetaxel | [40] |
| DPPC:CHO:DSPE-PEG90:5:5 | 5-Fluorouracil | [41] |
| DPPC:MPPC:DSPE-PEG200086:5:4 | Vinorelbine | [42] |
| DPPC: DSPE-PEG2000: MSPC75:17:8 | DOX + Vincristine | [43] |
| DPPC:MSPC:DSPE-PEG200085.3:9.7:5.0 | DOX + ProHance® | [44] |